Would I Lie to You?

As we enter the last few weeks of summer and students anticipate going back to school, we’re revisiting some favorite Bulletin segments about screens and technology. First, Krista Boan joins Russell Moore, Mike Cosper, and Clarissa Moll to discuss the rush to get technology into ...  Show more

This week, Israeli Prime Minister Benjamin Netanyahu visited President Donald Trump in the White House. His visit highlights the drawn out war in Iran, as well as growing antisemitism in the US. We re-air a conversation between Russell Moore and Rabbi Michael Holzman about the di ...  Show more

Ozempic and other new weight loss drugs are being touted as potential miracle cures for diabetes and obesity. Journalist Johann Hari experimented with the drug and dropped 40 pounds. In his new book, Magic Pill, Hari discusses his experience with Ozempic and speaks to many of the ...  Show more

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. ...

This week, I’m joined by Johann Hari, New York Times bestselling author, journalist, and speaker, to explore his journey into the world of the new weight loss drug phenomenon: Ozempic. Johann shares his surprising firsthand experience injecting himself weekly with the drug for ov ...  Show more

Ozempic. It started with a lizard, and then transformed into a drug that, depending on who you ask, is either a miracle or the downfall of society. New Yorker writer and cultural critic Jia Tolentino joins Trevor and Christiana to give context on the media circus surrounding w ...